Myriad Genetics | MYGN - Cost Of Sales

Myriad Genetics reported $53.9M in Cost of Sales for its fourth fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview
Cost Of Sales Change
Accelerate Diagnostics AXDX:US USD 2.38M 400K
Agilent A:US USD 788M 49M
Becton, Dickinson and BDX:US USD 2.45B 231M
Bio Rad Laboratories BIO:US USD 332.96M 27.25M
Biocept BIOC:US USD 5.78M 2.25M
Bruker BRKR:US USD 342.5M 38.7M
Danaher DHR:US USD 3.43B 351M
Exact Sciences EXAS:US USD 147.15M 785K
Fluidigm FLDM:US USD 15.85M 572K
Hologic HOLX:US USD 456.3M 26M
Illumina ILMN:US USD 411M 13M
Johnson & Johnson JNJ:US USD 7.76B 29M
Mettler Toledo International MTD:US USD 425.54M 24.36M
Myriad Genetics MYGN:US USD 53.9M 3.5M
Nanostring Technologies NSTG:US USD 21.12M 7.4M
Orasure Technologies OSUR:US USD 73.49M 3.22M
Pacific Biosciences Of California PACB:US USD 18.51M 256K
Perkinelmer PKI:US USD 304.88M 125K
Quest Diagnostics DGX:US USD 1.56B 56M
Quidel QDEL:US USD 417.5M 41.2M
Repligen RGEN:US USD 90.7M 4.19M
Thermo Fisher Scientific TMO:US USD 6.72B 340M
Veracyte VCYT:US USD 26.83M 823K
Waters WAT:US USD 348.19M 41.09M